Altimmune (ALT) Earnings Date & Reports

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases... Show more

Industry: #Miscellaneous Commercial Services

Get AI intraday signals

A.I. Advisor

published Earnings

ALT is expected to report earnings to rise 11.73% to -36 cents per share on May 08

Q1'25

Est.

$-0.37

Q4'24

Beat

by $0.01

Q3'24

Beat

by $0.04

Q2'24

Est.

$-0.35

Q1'24

Beat

by $0.04

The last earnings report on February 27 showed earnings per share of -33 cents, beating the estimate of -34 cents. With 1.13M shares outstanding, the current market capitalization sits at 455.92M.

View a ticker or compare two or three

Compare

ALT